Ursolic acid ameliorates CCl4-induced liver fibrosis through the NOXs/ROS pathway

Dakai Gan1, Wang Zhang2, Chenkai Huang2

  • 1Department One of Liver Disease, The Ninth Hospital of Nanchang, Nanchang, People's Republic of China.

Insights

Ursolic acid (UA) reverses liver fibrosis by reducing NADPH oxidases (NOXs) and reactive oxygen species (ROS) in liver cells. This treatment promotes hepatocyte proliferation and hepatic stellate cell apoptosis without impairing host defense.

Area of Science:

  • Hepatology
  • Cell Biology
  • Biochemistry

Background:

  • Liver fibrosis is a dynamic wound-healing process following liver injury.
  • NADPH oxidases (NOXs) and reactive oxygen species (ROS) are implicated in hepatic fibrosis development.
  • Ursolic acid (UA) demonstrated antifibrotic effects in vitro by inhibiting NOX-mediated signaling in hepatic stellate cells (HSCs).

Purpose of the Study:

  • To investigate the in vivo efficacy of ursolic acid (UA) in alleviating carbon tetrachloride (CCl4)-induced liver fibrosis.
  • To elucidate the mechanisms underlying UA's antifibrotic effects, focusing on NOX/ROS pathways in hepatocytes (HCs), HSCs, and Kupffer cells (KCs).

Main Methods:

  • CCl4-induced liver fibrosis model in vivo.
  • Assessment of UA's effects on NOX and ROS expression in HCs, HSCs, and KCs.
  • Evaluation of KC phagocytic activity (indices α and K).
  • Analysis of UA's impact on HC proliferation, HSC apoptosis, and KC activation.

Main Results:

  • UA alleviated CCl4-induced liver fibrosis by decreasing NOX and ROS expression across HCs, HSCs, and KCs.
  • UA treatment promoted HC proliferation and induced apoptosis in HSCs.
  • KC activation was prevented by UA, while phagocytic function remained unaffected.
  • UA did not compromise the host defense function.

Conclusions:

  • Ursolic acid (UA) effectively reverses liver fibrosis in vivo.
  • UA exerts its antifibrotic effects by modulating NOX/ROS pathways, promoting hepatocyte health, and inducing apoptosis in fibrogenic cells.
  • UA represents a potential therapeutic agent for liver fibrosis without compromising immune function.

Related Concept Videos

Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.3K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
895
The Citric Acid Cycle02:36

The Citric Acid Cycle

The citric acid cycle, also known as the Krebs cycle or TCA cycle, consists of several energy-generating reactions that yield one ATP molecule, three NADH molecules, one FADH2 molecule, and two CO2 molecules.
162.8K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
549
Other Glycolytic Pathways01:24

Other Glycolytic Pathways

The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...
990